I'm working on
4 months ago
Medicinal chemistry, kinase signaling, antivirals, oncology, neurodegeneration
About
Patrick Flaherty develops small‑molecule therapeutics across oncology, antivirals and neurodegeneration. He holds 3 issued patents and leads design on grants targeting MEK5/ERK5 and SARS‑CoV‑2 RdRp at Duquesne in collaboration with University of Pittsburgh.
Partnering listings
Learn more
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.Already have an account? Sign in
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.